12 February 2026 - Biotechnology company Celyad Oncology (Euronext Brussels:CYAD) announced on Thursday that it has sold its C-Cathez transendocardial catheter to CellProthera, including all intellectual property rights and technical documentation.Th...
12 February 2026 - Citius Oncology Inc (Nasdaq:CTOR), the oncology-focused subsidiary of biopharmaceutical company Citius Pharmaceuticals Inc (Nasdaq:CTXR), announced on Wednesday that it has signed a distribution agreement with Uniphar, an internati...